Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2003 | 01-2003 | 10-2002 | 07-2002 | 04-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -146 | -82 | -39 | -76 | -147 |
| Depreciation Amortization | 48 | 36 | 24 | 12 | 48 |
| Accounts receivable | N/A | 0 | -5 | 0 | N/A |
| Accounts payable and accrued liabilities | -23 | -53 | 1 | 48 | -38 |
| Other Working Capital | -151 | -200 | -133 | 17 | 16 |
| Other Operating Activity | 23 | 53 | 5 | -49 | 88 |
| Operating Cash Flow | $-248 | $-245 | $-147 | $-47 | $-33 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -11 | -9 | -5 | -14 |
| Other Investing Activity | 0 | 5 | 5 | 5 | 0 |
| Investing Cash Flow | $-9 | $-6 | $-4 | $0 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -2 | -2 | -2 | -10 |
| Other Financing Activity | 5 | 0 | 0 | 0 | 55 |
| Financing Cash Flow | $3 | $-2 | $-2 | $-2 | $45 |
| Beginning Cash Position | 449 | 449 | 449 | 449 | 452 |
| End Cash Position | 195 | 196 | 296 | 400 | 449 |
| Net Cash Flow | $-254 | $-253 | $-154 | $-49 | $-2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -248 | -245 | -147 | -47 | -33 |
| Capital Expenditure | -9 | -11 | -9 | -5 | -14 |
| Free Cash Flow | -257 | -256 | -157 | -52 | -47 |